Author

Daniel K. Beyer

NYU Langone Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Organism:yeast· 1

Frequent Co-Authors

David FenyöiD· 1 shared Gregory W. GoldbergiD· 1 shared Jef D. BoekeiD· 1 shared Kenenna OnyebekeiD· 1 shared Larisa KagermazovaiD· 1 shared Manjunatha KogenaruiD· 1 shared Marcus B. NoyesiD· 1 shared Mauricio A. Arias· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

David FenyöORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered transcription-associated Cas9 targeting in eukaryotic cells

Gregory W. Goldberg, Manjunatha Kogenaru, Sarah Keegan, Max A. B. Haase, Larisa Kagermazova, Mauricio A. Arias, Kenenna Onyebeke, Samantha Adams, Daniel K. Beyer, David Fenyö, Marcus B. Noyes, Jef D. Boeke

This paper introduces a method to temporally control Cas9 DNA targeting by coupling it with transcription through engineered RNA binding, enabling selective gene editing in yeast and human cells.

Nature Communications · Nov 27, 2024Peer-reviewedMolecular Biology